Israel Englander’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,137
Closed -$13.3K 6451
2026
Q1
$13.3K Sell
13,137
-21,584
-62% -$36.6K ﹤0.01% 5523
2025
Q4
$63.5K Buy
+34,721
New +$79.8K ﹤0.01% 5706
2024
Q2
Sell
-59
Closed -$5.45K 6596
2024
Q1
$5.45K Buy
+59
New +$5.25K ﹤0.01% 5998
2022
Q4
Sell
-7
Closed -$8K 7102
2022
Q3
$8K Buy
+7
New +$13.3K ﹤0.01% 6716
2019
Q1
Sell
-2
Closed -$4.01M 4369
2018
Q4
$4.01M Buy
+2
New +$4.71M 0.01% 1734
2018
Q3
Hold
0
2509

Other funds holding VTAK

Israel Englander's VTAK Position: Q2 2026 in Review

Israel Englander sold out of Catheter Precision (VTAK) in Q2 2026, closing a stake of 13,137 shares — an estimated $13.3K sold.

Israel Englander first reported a position in VTAK in Q4 2018 and held it in 5 quarters. The position peaked at $4.01M in Q4 2018. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • Israel Englander reported no remaining Catheter Precision position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 13,137 Catheter Precision shares in Q2 2026, an estimated $13.3K.
  • Israel Englander first reported a position in Catheter Precision in Q4 2018 and held it in 5 quarters.
  • Israel Englander's Catheter Precision position peaked at $4.01M in Q4 2018.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.